Disclosure Information

Disclosure of Conflicts of Interest

Global Education Group (Global) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global. All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias.

All relevant financial relationships have been mitigated.

The faculty has the following relevant financial relationships with ineligible companies:

 

Name of Faculty or Presenter 

Reported Financial Relationship 

Bassam A. Bassam, MD, FAAN                 

Speaker’s Bureau: Argenx Pharmaceuticals 

Gregory Bergey, FANA, FAAN, FAES 

Nothing to disclose 

Amy Brown, MD, MS 

Contracted Research: Teva Pharmaceuticals, Neurocrine Biosciences, Alterity Therapeutics, PTC Therapeutics, Novartis, F. Hoffmann-La Roche, Sage Therapeutics, Abbvie Pharmaceuticals 

Honoraria: Open Health; M-Panels; InCrowd 

Cherylee Chang, MD 

Nothing to disclose 

Larry Charleston, IV, MD, MSc, FAHS 

Consulting Fee: Allergan/AbbVie, Alder/Lundbeck, Amneal, Biohaven, Haleon, Satsuma and Teva 

Contracted Research: Disparities in Headache Advisory Council, Amgen 

Honoraria: American Headache Society, American Academy of Neurology, BrainWeekend, NeurologyWeek, Migraine360 CME Program 

Stock Option Holder: Was on the advisory panel for Ctrl M Health (stock) – now defunct 

Ciaran Considine, PhD, ABPP-CN 

Nothing to disclose 

Richard Ryan Darby, MD 

Nothing to disclose 

 

 

Mazen Dimachkie, MD 

Consulting Fee: Abcuro, Amazentis, ArgenX, Astellas, Catalyst, Cello, Covance/Labcorp, CSL-Behring, EcoR1, Janssen, Kezar, MDA, Medlink, Momenta, NuFactor, Octapharma, Priovant, RaPharma/UCB, Roivant Sciences Inc, Sanofi Genzyme, Shire Takeda, Scholar Rock, Spark Therapeutics, Abata/Third Rock, UCB Biopharma and UpToDate. 

Contracted Research: Alexion, Alnylam Pharmaceuticals, Amicus, Biomarin, Bristol-Myers Squibb, Catalyst, Corbus, CSL-Behring, FDA/OOPD, GlaxoSmithKline, Genentech, Grifols, Kezar, Mitsubishi Tanabe Pharma, MDA, NIH, Novartis, Octapharma, Orphazyme, Ra Pharma/UCB, Sanofi Genzyme, Sarepta Therapeutics, Shire Takeda, Spark Therapeutics, The Myositis Association, UCB Biopharma/RaPharma, Viromed/Healixmith & TMA. 

Honoraria: Abcuro, Amazentis, ArgenX, Astellas, Catalyst, Cello, Covance/Labcorp, CSL-Behring, EcoR1, Janssen, Kezar, MDA, Medlink, Momenta, NuFactor, Octapharma, Priovant, RaPharma/UCB, Roivant Sciences Inc, Sanofi Genzyme, Shire Takeda, Scholar Rock, Spark Therapeutics, Abata/Third Rock, UCB Biopharma and UpToDate. 

Royalty: UpToDate 

Ashley Ghiaseddin, MD 

Consulting Fee: Alexion Pharmaceuticals (Advisory Board 11/20/22), Consulting Agreement with Neosoma (but have not participated in consulting role as of yet this was just an agreement).

Stock Shareholder: Personal stock in Viatris Inc. 

Larry Goldstein, MD, FAHA, FAAN  

Other: Data Safety Monitoring Board for Janssen – support to university 

Amy Hessler, DO 

Nothing to disclose 

Casey Jeffreys, MD 

Consulting Fee: Genentech, Sanofi-Genzyme, EMD Serono 

Contracted Research: Novartis 

Mohamed Koubeissi, MD, MA, FAAN, FANA, FAES 

Speaker’s Bureau: SK Life Sciences Inc 

Laura Lehman, MD 

Nothing to disclose 

Sebastian Lopez, MD 

Consulting Fee: Horizon/Genentech 

Michael Malinzak, MD, PhD 

Nothing to disclose 

Katherine B. Peters, MD, PhD, FAAN 

Consulting Fee: Blue Earth Diagnostics, Sapience Therapeutics, Servier 

Contracted Research: Servier, Biomimetrix, Abbvie, Allergan, Varian, Sapience Therapeutics, Novocure 

Honoraria: Eisai 

Stock Option Holder: NuVox 

Aparna Ashutosh Wagle Shukla, MD 

Consulting Fee: Sage-Biogen, Supernus, Merz, Acadia 

Contracted Research: NIH 

Honoraria: Elsevier, Neurodiem, NIH 

Other: Tremor Research Group Vice President 

Colleen Stack, MD, MBA 

Nothing to disclose 

Kiran Thakur, MD 

Nothing to disclose 

Sarah Zallek, MD 

Nothing to disclose 

 

The planners and managers have the following relevant financial relationships with ineligible companies:

 

Name of Planner or Manager 

Reported Financial Relationship 

Lindsay Borvansky 

Nothing to disclose 

Ashley Cann 

Nothing to disclose 

Alexa DeVantier 

Nothing to disclose 

Grace Freeman 

Nothing to disclose 

Andrea Funk 

Nothing to disclose 

Josh Jones 

Nothing to disclose 

Liddy Knight 

Nothing to disclose 

Lisa Maher 

Nothing to disclose 

Michelle Winokur, DrPH 

Nothing to disclose 

 

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. 

 

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and Institute for Patient Access do not recommend the use of any agent outside of the labeled indications. 

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.